Fund Information / Factsheet • Dec 22, 2025
Fund Information / Factsheet
Open in ViewerOpens in native device viewer
Factsheet - at 30 November 2025 Marketing Communication


| Performance over (%) |
6m | 1y | 3y | 5y | 10y |
|---|---|---|---|---|---|
| Share price (Total return) |
17.0 | 12.2 | 32.9 | 88.5 | 219.4 |
| NAV (Total return) |
16.0 | 7.9 | 27.1 | 77.4 | 198.3 |
| Reference Index (Total return) |
14.3 | 2.9 | 26.6 | 77.7 | 200.5 |
| Relative NAV (Total return) |
1.7 | 5.0 | 0.5 | -0.3 | -2.2 |
| Discrete year performance (%) |
Share price (total return) |
NAV (total return) |
|---|---|---|
| 30/9/2024 to 30/9/2025 |
20.1 | 13.5 |
| 30/9/2023 to 30/9/2024 |
15.1 | 15.2 |
| 30/9/2022 to 30/9/2023 |
-3.1 | 5.1 |
| 30/9/2021 to 30/9/2022 |
8.1 | 6.9 |
| 30/9/2020 to 30/9/2021 |
34.2 | 24.9 |
Source: at 30/11/25. © 2025 Morningstar, Inc. All rights reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete, or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance does not predict future returns.
All performance, cumulative growth and annual growth data is sourced from Morningstar.
The Investment management and administration transferred to Janus Henderson Investors on 1 August 2024.
In the month under review the Company's NAV total return was 2.5% and the Russell 1000® Value Index total return was 1.8% in sterling terms and the S&P High Yield Dividend Aristocrats® total return was 1.8% in sterling terms.
Stock selection in financial services, consumer discretionary and consumer staples added to performance, with tobacco company Philip Morris a key contributor. Dell Technologies and global animal health company Zoetis detracted.
We believe the companies held in the portfolio are well positioned for periods of volatility. Their highquality nature could help insulate them against some of the macroeconomic forces at play.
References made to individual securities do not constitute a recommendation to buy, sell or hold any security, investment strategy or market sector, and should not be assumed to be profitable. Janus Henderson Investors, its affiliated advisor, or its employees, may have a position in the securities mentioned.
The Company aims to provide investors with above average dividend income and long-term capital growth through active management of a portfolio consisting predominantly of S&P 500 US equities.
Seeks to provide income with the potential for growth, offering UK investors diversification through exposure to the US.
| NAV (cum income) | 397.8p |
|---|---|
| NAV (ex income) | 393.6p |
| Share price | 366.0p |
| Discount(-)/premium(+) | -8.0% |
| Yield | 3.4% |
| Net gearing | 7% |
| Net cash | - |
| Total assets | £492m |
| Net assets | £456m |
| Market capitalisation | £420m |
| Total voting rights | 114,764,779 |
| Total number of holdings | 56 |
| Ongoing charges (year end 31 Jan 2025) |
0.77% |
| Reference Index | Russell 1000® Value Index |
Source: BNP Paribas for holdings information and Morningstar for all other data. Differences in calculation may occur due to the methodology used.
Please note that the total voting rights in the Company do not include shares held in Treasury.
The Company has no benchmark, but the most relevant reference index for the Company is the Russell 1000 Value Index (in sterling terms) and most of the holdings in the portfolio are likely to be drawn from its constituents.
Please remember that past performance does not predict future returns. The value of an investment and the income from it can rise as well as fall as a result of market and currency fluctuations, and you may not get back the amount originally invested. Please refer to the glossary for the definition of share price total return.
How to invest
declared but not yet paid.
Go to www.janushenderson.com/howtoinvest
Go to www.northamericanincome.com
Factsheet - at 30 November 2025 Marketing Communication
| Top 10 holdings | (%) |
|---|---|
| Chevron | 4.2 |
| CVS Health | 3.7 |
| Philip Morris International | 3.7 |
| Johnson & Johnson | 3.5 |
| Lamar Advertising | 3.3 |
| Medtronic | 3.3 |
| Citigroup | 3.2 |
| Morgan Stanley | 3.2 |
| Xcel Energy | 3.1 |
| Enbridge | 3.0 |
References made to individual securities do not constitute a recommendation to buy, sell or hold any security, investment strategy or market sector, and should not be assumed to be profitable. Janus Henderson Investors, its affiliated advisor, or its employees, may have a position in the securities mentioned.


The above sector breakdown may not add up to 100% due to rounding.


All performance, cumulative growth and annual growth data is sourced from Morningstar. Share price total return is calculated using mid-market share price with dividends reinvested.
Please remember that past performance does not predict future returns. The value of an investment and the income from it can rise as well as fall as a result of market and currency fluctuations, and you may not get back the amount originally invested. Please refer to the glossary for the definition of share price total return.
Go to www.janushenderson.com/howtoinvest
Customer services 0800 832 832
| Stock code | NAIT | |
|---|---|---|
| AIC sector | AIC North America | |
| Reference Index | Russell 1000® Value Index |
|
| Company type | Conventional (Ords) | |
| Launch date | 1902 | |
| Financial year | 31-Jan | |
| Dividend payment | Feb / Jun / Aug / Oct | |
| Management fee | 0.55% of NAV up to £500m and 0.45% of NAV in excess thereof |
|
| Performance fee | No | |
| (See Annual Report & Key Information Document for more information) |

Fund manager appointment
Fran Radano, CFA Portfolio Manager
Regional focus North America

Jeremiah Buckley, CFA Portfolio Manager
Fran Radano 2024 Jeremiah Buckley 2024
Factsheet - at 30 November 2025 Marketing Communication

US equities rose over November. Waning expectations of a near-term interest-rate cut by the US Federal Reserve (Fed), along with worries about high valuations in artificial intelligence (AI)-related stocks, caused sharp losses earlier on. However, the equity market subsequently rebounded as investors grew increasingly optimistic that the Fed would in fact loosen monetary policy in December. This followed more benign inflation readings while several alternative employment statistics (given the government shutdown) made the case that employment trends may weaken, despite an impressive September non-farm payrolls print of 119,000.
Additional economic news was mixed. The purchasing managers' index (PMI) increased to a better-thanforecast 54.8 in November, led by the services sector. Meanwhile, consumer confidence weakened to a sevenmonth low in November and retail sales rose only modestly.
Stock selection in the financial services, consumer discretionary and consumer staples sectors added to performance, with tobacco company Philip Morris being a key positive contributor. The overweight allocation to healthcare also added value, with healthcare technology company Medtronic contributing positively. Conversely, stock selection in the communication services and industrials sectors detracted.
In terms of individual stocks, Lamar Advertising and biotechnology company Amgen both contributed positively. Dell Technologies and global animal health company Zoetis detracted. Not holding technology giant Alphabet also detracted.
In terms of activity, we introduced new positions in engineering company Emerson and Royal Caribbean Cruises. We reduced the position in the technology sector by trimming the holdings in semiconductor industry suppliers Lam Research Group and Broadcom after periods of strong share price performance.
The implementation of US trade tariffs is essentially adding a consumption tax that will be absorbed by some combination of exporters (non-US), importers (US) and the consumer/corporate end user. However, when combined with the fiscal policy laid out in the 'One Big Beautiful Bill' that allows for expensing of capital expenditure, research and development (R&D) and more generous interest expense deductions, we think there is an interesting offsetting balance in aggregate, which does not even contemplate the longer-term ability of the US to create jobs. Furthermore, the consumer will experience several enhanced tax deductions that will begin to occur in 2026. In our opinion, it seems that 'uncertainty' has been the biggest headwind for corporates and global trading partners, not the ultimate level of the trade tariffs, so the outlook has improved markedly from the beginning of the year.
We believe going forward that the labour market is a bigger risk than inflation, as there were several large jobcut announcements, while jobless claims remain elevated as there has been an inability for many of those laid off to find employment. Meanwhile, higher interest rates disproportionately impact small business, so the loosening of monetary policy should be helpful to this important employment cohort.
On the corporate side, we do not believe current fundamentals and the forward outlook are as negative as they may be perceived externally. That said, market valuations remain broadly elevated, so we need to remain selective, diligent and disciplined in our investment strategy.
The third-quarter earnings season was the fifth consecutive quarter of at least 10% earnings-per-share (EPS) growth with revenues up in the high-single digits and earnings approaching the mid-teens. There have been some corporate credit concerns, but we believe these are idiosyncratic and not something that will be pervasive. The impacts of trade tariff continue to be modest and have not driven inflation as predicted, while employment moves to the forefront as a potential risk following some high visibility redundancy headlines from the private sector.
We believe the companies we hold are well positioned to manage through periods of volatility. We also feel comfortable with the current valuations of these companies, which in aggregate were trading at around 16x forward earnings, which marks a discount to market averages.
Factsheet - at 30 November 2025 Marketing Communication
We feel the high-quality nature of these holdings should help insulate them against some of the macroeconomic forces at play. From a revenue perspective, we think the historically predictable cash generation and robust balance sheets should lead to continued dividend growth prospects for the rest of 2025 and into next year. We continue to seek resilient companies, where macroeconomic tailwinds are not needed for growth, and where we think they have the cash and ability to invest in themselves for the future.
Factsheet - at 30 November 2025 Marketing Communication
The amount by which the price per share of an investment company is either lower (at a discount) or higher (at a premium) than the net asset value per share (cum income), expressed as a percentage of the net asset value per share.
The effect of borrowing money for investment purposes (financial gearing). The amount a company can "gear" is the amount it can borrow in order to invest. Gearing is used in the expectation that the returns on the investments bought will exceed the costs of the borrowings that funded the purchase. This Company can also use synthetic gearing through derivatives and foreign exchange hedging and/or other non-fully funded instruments or techniques.
The Company's leverage is the sum of financial gearing and synthetic gearing. Details of the Company's leverage limits can be found in both the Key Information Document and Annual Report. Where a company utilises leverage, the profits and losses incurred by the company can be greater than those of a company that does not use leverage.
Share price multiplied by the number of shares in issue, excluding treasury shares, at month end. Shares typically priced mid-market at month-end closing.
The total value of a Company's assets less its liabilities.
The value of investments and cash, including current year revenue, less liabilities (prior charges such as loans, debenture stock and preference shares at fair value).
The value of investments and cash, excluding current year revenue, less liabilities (prior charges such as loans, debenture stock and preference shares at fair value).
The theoretical total return on shareholders' funds per share reflecting the change in Net Asset Value (NAV) assuming that dividends paid to shareholders were reinvested at NAV at the time the shares were quoted ex-dividend. A way of measuring investment management performance of investment trusts which is not affected by movements in discounts/premiums.
Total assets minus any liabilities such as bank loans or creditors.
A company's net exposure to cash/cash equivalents expressed as a percentage of shareholders' funds, after any offset against its gearing. This is only shown for companies that have gearing in place.
A company's total assets (less cash/cash equivalents) divided by shareholders' funds expressed as a percentage.
The total expenses for the financial year (excluding performance fee), divided by the average daily net assets, multiplied by 100.
Closing mid-market share price at month end.
The theoretical total return to the investor assuming that all dividends received were reinvested in the shares of the company at the time the shares were quoted ex-dividend. Transaction costs are not taken into account.
Cum Income NAV multiplied by the number of shares, plus prior charges at fair value.
Calculated by dividing the current financial year's dividends per share (this will include prospective dividends) by the current price per share, then multiplying by 100 to arrive at a percentage figure.
For a full list of terms please visit: https://www.janushenderson.com/engb/investor/glossary/
Factsheet - at 30 November 2025 Marketing Communication
Overall Morningstar Rating™ is shown for an investment company achieving a rating of 4 or 5.
Janus Henderson Fund Managers UK Limited was appointed as the AIFM of the North American Income Trust with effect from 1 August 2024. Prior to that date, the North American Income Trust's AIFM was abrdn Fund Managers Limited and all information contained in this document should be considered accordingly.
Not for onward distribution. Before investing in an investment trust referred to in this document, you should satisfy yourself as to its suitability and the risks involved, you may wish to consult a financial adviser. This is a marketing communication. Please refer to the AIFMD Disclosure document and Annual Report of the AIF before making any final investment decisions. Past performance does not predict future returns. The value of an investment and the income from it can fall as well as rise and you may not get back the amount originally invested. Tax assumptions and reliefs depend upon an investor's particular circumstances and may change if those circumstances or the law change. Nothing in this document is intended to or should be construed as advice. This document is not a recommendation to sell or purchase any investment. It does not form part of any contract for the sale or purchase of any investment. We may record telephone calls for our mutual protection, to improve customer service and for regulatory record keeping purposes.
Issued in the UK by Janus Henderson Investors. Janus Henderson Investors is the name under which investment products and services are provided by Janus Henderson Investors International Limited (reg no. 3594615), Janus Henderson Investors UK Limited (reg. no. 906355), Janus Henderson Fund Management UK Limited (reg. no. 2678531), Tabula Investment Management Limited (reg. no. 11286661), (each registered in England and Wales at 201 Bishopsgate, London EC2M 3AE and regulated by the Financial Conduct Authority) and Janus Henderson Investors Europe S.A. (reg no. B22848 at 78, Avenue de la Liberté, L-1930 Luxembourg, Luxembourg and regulated by the Commission de Surveillance du Secteur Financier). Janus Henderson® and any other trademarks used herein are trademarks of Janus Henderson Group plc or one of its subsidiaries. © Janus Henderson Group plc.
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.